4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-15-039317
Director sold 13,205 shares at an average $7.33 ($96,781)
- Director acquired 13,205 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kraus Al · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-06-24 | Exercise or conversion : show line 1 in the form | +3,205 | $5.50 | $17,628 | 58,746 | D |
| 2015-06-24 | Sale : show line 2 in the form | −3,205 | $7.00 | $22,435 | 55,746 | D |
| 2015-06-25 | Exercise or conversion : show line 3 in the form | +10,000 | $0.88 | $8,750 | 65,746 | D |
| 2015-06-25 | Sale : show line 4 in the form | −10,000 | $7.43 | $74,346 | 55,746 | D |
| Open-market sales · 13,205 sh · avg $7.33 · $96,781 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-06-24 | Exercise or conversion : show line 5 in the form Stock Option | −3,205 | 0 | D |
| 2015-06-15 | Exercise or conversion : show line 6 in the form Stock Option | −10,000 | 166,773 | D |
Loading xslF345X03/v414210_4.xml…